Defined GalNAc architecture • P(III) integrity • Solid-phase compatibility

GalNAc Phosphoramidite Synthesis Services

BOC Sciences supports custom GalNAc phosphoramidite synthesis for incorporation into research oligonucleotides by solid-phase chemistry. Projects define the GalNAc ligand, linker, phosphoramidite attachment site, and protection pattern, with material characterization and optional coupling evaluation scoped for the intended synthesis cycle.

  • Monovalent and specified multivalent GalNAc ligand amidites
  • Moisture-sensitive and oxidation-sensitive P(III) functionality
  • Identity, phosphorus NMR, and process-specific compatibility evidence

Discuss Your Target Explore Synthesis Options

Conceptual GalNAc ligand-to-phosphoramidite workflow emphasizing dry handling, oxidation control, phosphorus NMR, and defined solid-phase coupling.Conceptual example of a multivalent GalNAc reagent workflow. Ligand valency, incorporation position, and synthesis-cycle compatibility are defined separately.

Project specification

Define the target and intended use
01 Complete ligand and linker drawing
02 GalNAc valency and stereochemistry
03 Phosphoramidite site and functionality
04 Terminal or internal incorporation plan
05 Activator and deprotection program
06 Amount, packaging, and QC needs

Custom synthesis scope

Custom GalNAc Amidites for Defined Incorporation Strategies

GalNAc phosphoramidite is a family description, not a unique molecular structure. Monovalent building blocks, preassembled ligand clusters, and different linkers can have different coupling and deprotection requirements. The target drawing specifies every component, including whether an additional protected hydroxyl is available for continued chain extension.

01
Modular ligand design

Monovalent GalNAc Amidite Building Blocks

Prepare a specified single-GalNAc building block carrying the requested linker and phosphoramidite functionality. The ligand stereochemistry, branch-point identity, and any hydroxyl protecting group are defined explicitly. Multiple incorporations may build a ligand arrangement, but the number and spacing of residues depend on the oligonucleotide design and supported coupling sequence.

  • Defined GalNAc and linker structure
  • Terminal-only or chain-extensible architecture
  • Complete protection map
02
Clustered ligands

Preassembled Multivalent Ligand Amidites

Discuss a preassembled GalNAc cluster with defined valency, branching scaffold, linker length, and phosphoramidite attachment site. A triantennary ligand is one specified architecture, not an interchangeable description for every three-GalNAc construct. Steric size, solubility, and reagent purity are considered in relation to the intended coupling.

  • Valency and branch scaffold specified
  • Phosphitylation site identified
  • Cluster and amidite impurities considered separately
03
Route customization

Linker and Protection-Pattern Customization

Assess a requested spacer, branch point, or protection change against the oligonucleotide cycle. A building block intended for internal incorporation needs a compatible continuation site and removal sequence. A reagent without that functionality may be suitable only for a terminal addition. Compatibility is defined for the exact structure rather than inferred from the GalNAc name.

  • Spacer and incorporation position aligned
  • Acid, base, and oxidation exposure reviewed
  • Final ligand state after deprotection defined
04
Functional assessment

Coupling Compatibility Evaluation

Add an agreed evaluation using a specified oligonucleotide, support, activator, and cycle. The test can examine conversion, conjugate identity, and relevant side products after cleavage and deprotection. A model result is reported within its tested conditions and does not establish universal instrument, sequence, or backbone compatibility.

  • Defined test construct and synthesis program
  • Conjugated versus unconjugated species assessed
  • Reagent supply separated from conjugate production
Six separate GalNAc phosphoramidite compatibility checks cover coupling, capping, oxidation or sulfurization, acid treatment, cleavage, and deprotection.

Target-specific route assessment

Preserve Phosphoramidite Integrity from Synthesis to Use

The ligand precursor and P(III) reagent require different handling considerations. Route planning connects selective phosphitylation with the purity, packaging, and solution behavior needed for the intended solid-phase operation.

Control the Phosphitylation Site

Unintended exposed hydroxyls can generate differently phosphitylated or multifunctional species. The precursor protection pattern and target attachment site are reviewed before the final step. The GalNAc ligand remains structurally defined rather than being represented only by a phosphorus-containing mass.

Address Water and Oxidation Separately

Phosphoramidites are susceptible to hydrolysis and oxidation. Dry handling and protection from incompatible exposure are therefore planned for the material and its solution preparation. Water content and phosphorus-species analysis answer different questions; neither should be substituted for the other.

Evaluate the Complete Synthesis Cycle

Coupling, capping, oxidation or sulfurization, acid treatment, cleavage, and deprotection can each affect the reagent or final ligand. The applicable sequence depends on whether the GalNAc unit is terminal or internal. Solubility at the intended concentration is considered alongside chemical stability.

Discuss the Synthesis Route

Material and project decisions

Distinguish Reagent Quality from Oligonucleotide Compatibility

Acceptance criteria should connect a measurement to the decision it supports. No single assay establishes ligand identity, P(III) integrity, dryness, and functional performance at the same time.

Acceptance questionMeasurement or testWhat it establishesBoundary
Is the intended ligand present?Appropriate 1H/13C NMR and mass analysisConsistency with GalNAc, linker, and protected derivative identityDoes not alone establish coupling efficiency
What phosphorus species are detected?31P NMR under recorded conditionsPhosphorus environments and detectable related P-containing speciesPeak count or area alone is not universal chemical purity
Is water content suitable for use?A justified water-content method, such as an appropriate Karl Fischer methodWater result for the tested sample and methodRequires method suitability for the sensitive matrix
Is chemical purity acceptable?A compatible chromatographic method and defined reporting basisDetectable precursor and related chemical speciesUV area may not represent all nonchromophoric impurities equally
Will the reagent work in the intended cycle?A defined coupling, cleavage, and deprotection testPerformance for the tested construct and conditionsDoes not prove compatibility with all sequences or supports

Our Glycoconjugate Synthesis Service provides broader conjugation context. Reagent synthesis, complete oligonucleotide manufacture, and biological evaluation are separate project scopes.

Structure-to-data consistency

Interpret Phosphorus NMR Alongside Orthogonal Identity Data

The analytical package addresses both the carbohydrate ligand and the reactive phosphorus functionality. Proposed specifications are set for the actual molecular structure, without assuming a universal phosphorus shift, purity threshold, or coupling yield.

Explore Glycan Separation

Phosphorus

31P NMR Species Profile

Record solvent, reference, acquisition conditions, and the relevant phosphorus signals. A phosphoramidite with a stereogenic phosphorus center can display diastereomeric signals in a chiral molecule; those signals do not automatically indicate an impurity. Hydrolysis or oxidation assignments need suitable supporting evidence.

Ligand identity

Structure and Attachment Site

Suitable NMR and mass data support the GalNAc configuration, linker, protection pattern, and intended derivative. The analytical approach accounts for possible handling-related degradation. Mass analysis alone cannot establish every stereochemical feature or phosphitylation position.

Use condition

Dryness, Solubility, and Packaging

Discuss a suitable water-content test, residual-solvent requirements, and solution concentration where relevant. Packaging can be planned around the intended use pattern. Storage temperature, reconstitution solvent, and use period follow the exact reagent and available evidence rather than a class-wide shelf-life claim.

Functional product

Post-Cleavage Conjugate Analysis

When a coupling test is included, assess the final conjugate after the intended cleavage and deprotection steps. LC-MS and suitable separation can help distinguish conjugated, unconjugated, and related products. Reagent identity data remain separate from the functional test report.

Research applications

Research Applications for Defined GalNAc Phosphoramidites

GalNAc is used in oligonucleotide ligand research, including ASGPR-related studies. The reagent provides a chemical route to a defined construct; receptor binding, uptake, activity, and safety require their own experimental evaluation.

GalNAc-Oligonucleotide Research Constructs

Introduce a defined ligand at a supported terminal or internal position. The building-block architecture and synthesis program determine the accessible construct. Ligand incorporation does not by itself establish delivery or biological performance.

Ligand Architecture Comparison

Compare valency, linker spacing, branch scaffold, or incorporation position while keeping other selected variables consistent. Each design remains a distinct reagent and conjugate, with structure-specific coupling and characterization requirements.

Solid-Phase Process Development

Evaluate reagent concentration, activator exposure, coupling time, and downstream deprotection in a defined process. The resulting data support that process-development question rather than a universal compatibility claim.

A defined synthesis project

Translate a GalNAc Conjugate Design into an Amidite Specification

The intended final construct defines the reagent architecture. The project then separates precursor synthesis, P(III) reagent quality, and any requested functional demonstration.

Project brief

Send the structure and project requirements

Share the ligand structure, valency, linker, incorporation position, support and activator, complete synthesis cycle, quantity, and QC requirements.

Start an Inquiry

1 Define the Final Construct

Confirm the ligand valency, linker, attachment point, terminal or internal location, and final protection-free structure. Determine whether continued chain extension is required.

2 Design the Protected Precursor

Identify the OH that will be phosphitylated and groups that must remain protected. Review sensitivity to the planned synthesis and deprotection conditions.

3 Agree on the Reagent Evidence Package

Specify identity tests, 31P NMR, purity reporting, optional water analysis, packaging, and any solution-form requirements. Record the acceptance basis for each item.

4 Prepare and Isolate the Amidite

Use the assessed route with handling appropriate to the P(III) functionality. Evaluate chemical condition and relevant related species before release against the agreed specification.

5 Evaluate Compatibility Where Commissioned

Perform the defined coupling study if included, then report the tested construct, conditions, and post-cleavage results. Provide sample-specific handling information with the reagent.

Project advantages

Advantages of a Reagent-to-Cycle GalNAc Project Scope

BOC Sciences connects ligand structure with the chemistry used to install it. This makes the proposal useful for both reagent selection and the evaluation of a particular solid-phase workflow.

Architecture Defined Before Synthesis

Valency, linker, phosphitylation site, and continuation functionality are recorded explicitly, reducing ambiguity between similarly named GalNAc reagents.

Separate Chemical and Functional Criteria

Reagent identity and phosphorus integrity are assessed independently from coupling performance, so a material result is not mistaken for a complete process demonstration.

Handling Included in the Material Plan

Dryness, packaging, and solution requirements are considered alongside the requested amount, with guidance tied to the actual structure and evidence.

Traceable Compatibility Evaluation

Optional functional studies identify the exact construct and cycle tested, making their practical limits clear for subsequent process decisions.

One connected glycan platform

Connect GalNAc Phosphoramidite Synthesis with Related Services

Related insights

Resources for GalNAc Phosphoramidite Synthesis

Explore supporting information on synthesis, characterization, and material selection for your project.

Analytical Techniques for Glycan CharacterizationPurification of Synthesized Glycans: Chromatographic Techniques ExplainedApplications of Synthetic Glycans in Biopharma Research

Frequently asked questions

GalNAc Phosphoramidite Synthesis FAQ

Answers to common questions about the requested structures, characterization, and project scope.

Is every GalNAc phosphoramidite suitable for internal incorporation?

No. Internal incorporation requires an architecture that supports both attachment and subsequent chain extension, with a compatible protecting-group sequence. Some structures are terminal modifiers. The complete drawing and intended cycle determine the appropriate use.

References

  1. Yamamoto T et al. Synthesis of Monovalent N-Acetylgalactosamine Phosphoramidite for Liver-Targeting Oligonucleotides. Current protocols in nucleic acid chemistry, 2019, 78(1):e99. DOI: 10.1002/cpnc.99.
  2. Ulashchik EA et al. Synthesis of GalNAc-Oligonucleotide Conjugates Using GalNAc Phosphoramidite and Triple-GalNAc CPG Solid Support. Methods in molecular biology (Clifton, N.J.), 2021, 2282:101-118. DOI: 10.1007/978-1-0716-1298-9_7.
  3. Cedillo I et al. Synthesis of 5'-GalNAc-Conjugated Oligonucleotides: A Comparison of Solid and Solution-Phase Conjugation Strategies. Molecules (Basel, Switzerland), 2017, 22(8):E1356. DOI: 10.3390/molecules22081356.

Define the research material your project needs

Plan a GalNAc Phosphoramidite for Your Solid-Phase Workflow

Send BOC Sciences the complete ligand and linker drawing, intended incorporation position, synthesis cycle, and required amount. Include phosphorus NMR, water-content, purity, packaging, and coupling-test requirements where relevant. We can review a project-specific reagent and evidence package that connects the molecular design with your research oligonucleotide workflow.

Contact BOC Sciences to discuss target-specific feasibility, specifications, and the required analytical package. Materials are intended for research use.

Request a Custom Quote
* Only for research. Not suitable for any diagnostic or therapeutic use.
Send Inquiry
Verification code